Your browser doesn't support javascript.
loading
Aggressiveness of Grade 4 Gliomas of Adults.
Deacu, Mariana; Docu Axelerad, Any; Popescu, Steliana; Topliceanu, Theodor Sebastian; Aschie, Mariana; Bosoteanu, Madalina; Cozaru, Georgeta Camelia; Cretu, Ana Maria; Voda, Raluca Ioana; Orasanu, Cristian Ionut.
Affiliation
  • Deacu M; Clinical Service of Pathology, Departments of Pathology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
  • Docu Axelerad A; Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
  • Popescu S; Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
  • Topliceanu TS; Department of Neurology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
  • Aschie M; Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
  • Bosoteanu M; Department of Radiology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
  • Cozaru GC; Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), "Ovidius" University of Constanta, 900591 Constanta, Romania.
  • Cretu AM; Clinical Service of Pathology, Departments of Pathology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
  • Voda RI; Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
  • Orasanu CI; Academy of Medical Sciences of Romania, 030167 Bucharest, Romania.
Clin Pract ; 12(5): 701-713, 2022 Sep 03.
Article in En | MEDLINE | ID: mdl-36136867
Grade 4 adult gliomas are IDH-mutant astrocytomas and IDH-wildtype glioblastomas. They have a very high mortality rate, with survival at 5 years not exceeding 5%. We aimed to conduct a clinical imaging and morphogenetic characterization of them, as well as to identify the main negative prognostic factors that give them such aggressiveness. We conducted a ten-year retrospective study. We followed the clinical, imaging, and morphogenetic aspects of the cases. We analyzed immunohistochemical markers (IDH1, Ki-67, and nestin) and FISH tests based on the CDKN2A gene. The obtained results were analyzed using SPSS Statistics with the appropriate parameters. The clinical aspects representing negative prognostic factors were represented by patients' comorbidities: hypertension (HR = 1.776) and diabetes mellitus/hyperglycemia (HR = 2.159). The lesions were mostly supratentorial, and the temporal lobe was the most affected. The mean volume was 88.05 cm3 and produced a midline shift with an average of 8.52 mm. Subtotal surgical resection was a negative prognostic factor (HR = 1.877). The proliferative index did not influence survival rate, whereas CDKN2A gene mutations were shown to have a major impact on survival. We identified the main negative prognostic factors that support the aggressiveness of grade 4 gliomas: patient comorbidities, type of surgical resection, degree of cell differentiation, and CDKN2A gene mutations.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Clin Pract Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Clin Pract Year: 2022 Document type: Article Affiliation country: Country of publication: